Skip to main content
Yantai Zhenghai Bio-Tech Co., Ltd. logo

Yantai Zhenghai Bio-Tech Co., Ltd. — Investor Relations & Filings

Ticker · 300653 ISIN · CNE100002NZ1 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 970 across all filing types
Latest filing 2023-04-10 AGM Information
Country CN China
Listing Shenzhen Stock Exchange 300653

About Yantai Zhenghai Bio-Tech Co., Ltd.

https://www.zhbio.com

Yantai Zhenghai Bio-Tech Co., Ltd. specializes in the research, development, production, and sale of regenerative medicine materials. The company focuses on tissue engineering and biomaterials to provide solutions for clinical repair and functional reconstruction. Its core product portfolio includes the Heal-All oral repair membrane, absorbable hard cerebral (spinal) membrane patches, and skin repair membranes. These products are widely utilized in stomatology, neurosurgery, and orthopedics. The company leverages advanced processing technologies to ensure biocompatibility and safety in its medical devices. By integrating research with clinical needs, it develops innovative bone repair materials and other biological scaffolds designed to facilitate natural tissue regeneration.

Recent filings

Filing Released Lang Actions
关于召开2022年年度股东大会的通知
AGM Information Classification · 100% confidence The document is a detailed notice about the convening of the 2022 Annual General Meeting (AGM) of 烟台正海生物科技股份有限公司. It includes information about the meeting date, voting procedures, agenda items such as approval of the 2022 annual report and financial statements, and instructions for shareholders to attend and vote either in person or online. The document does not contain the actual annual report or financial statements but rather serves as an official notification to shareholders about the AGM and the matters to be discussed and voted upon. The document length is about 5065 characters, which is consistent with a notice rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R).
2023-04-10 Chinese
天职业字[2023]15643号-控股股东及其他关联方资金占用情况的专项说明
Audit Report / Information Classification · 95% confidence The document is a special explanation regarding the 2022 non-operating funds occupation and other related party fund transactions of the controlling shareholder and other related parties of Yantai Zhenghai Biotechnology Co., Ltd. It includes an audit report with an unqualified opinion on the company's 2022 financial statements and a detailed summary table of non-operating fund occupation and related party transactions. The document is focused on audit findings related to related party transactions and fund occupation, referencing regulatory requirements from the China Securities Regulatory Commission and other authorities. It is not a full annual report but a standalone audit-related report focusing on a specific audit area (related party fund occupation). The document length is about 3245 characters, which is relatively short but contains substantive audit information and tables. It is not merely an announcement or certification but contains audit results and detailed data. Therefore, it fits best into the category of Audit Report / Information (AR). FY 2022
2023-04-10 Chinese
2022年度董事会工作报告
Board/Management Information Classification · 95% confidence The document is titled '董事会工作报告' which translates to 'Board of Directors Work Report' for the year 2022. It details the activities, meetings, and resolutions of the company's board of directors throughout the year, including financial performance summaries, governance activities, committee operations, independent directors' duties, shareholder meetings, and future outlook. The content focuses on the board's work and management rather than presenting full financial statements or comprehensive annual financial data. It is a detailed report on board and management activities rather than a full annual report or audit report. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length is 4095 characters, which is relatively short and consistent with a management or board report rather than a full annual report (10-K) or interim report (IR).
2023-04-10 Chinese
公司2022年度内部控制评价报告
Audit Report / Information Classification · 95% confidence The document is titled '2022年度内部控制评价报告' which translates to '2022 Annual Internal Control Evaluation Report' for the company 烟台正海生物科技股份有限公司. It discusses the evaluation of the company's internal control effectiveness as of December 31, 2022, including financial and non-financial internal control defects, internal control scope, work basis, and conclusions. The document is detailed and contains substantive content about internal control evaluation, not just an announcement or certification. It is not a full annual report (10-K) but a standalone internal control evaluation report, which fits the definition of an Audit Report / Information (AR). The length (8270 characters) and content confirm it is a full report, not a brief announcement or certification. Therefore, the appropriate classification is AR (Audit Report / Information). FY 2022
2023-04-10 Chinese
2022年年度报告
Annual Report Classification · 100% confidence The document is titled as the "2022 Annual Report" of 烟台正海生物科技股份有限公司 (Yantai Zhenghai Bio-Tech Co., Ltd.). It contains detailed sections typical of an annual report, including company overview, financial data, management discussion and analysis, corporate governance, social responsibility, and financial statements. The document includes audited financial data, management's discussion of business performance, risk factors, product information, and other comprehensive disclosures required in an annual report. The length of the document (15,000 characters) and the presence of substantive financial and operational data confirm it is the full annual report, not just an announcement or summary. Therefore, the appropriate classification is Annual Report (10-K). FY 2022
2023-04-10 Chinese
关于补选第三届董事会专门委员会委员的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the election of a new member to a specialized committee of the company's board of directors. It details the composition of various board committees and the appointment of a new committee member. There is no financial data, no mention of annual or quarterly reports, no voting results, and no regulatory filings beyond the committee change. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management.
2023-04-10 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.